You are here

  • Home
  • Archive
  • Volume 75, Issue 10
  • Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice

Article metrics

Article menu
Short report
Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice

 

Online download statistics by month:

Online download statistics by month: October 2021 to September 2024

AbstractFullPdf
Oct 202118317756
Nov 202113012778
Dec 202110610535
Jan 202211011130
Feb 20229710227
Mar 2022807820
Apr 2022858820
May 2022808526
Jun 2022666819
Jul 2022717514
Aug 2022596024
Sep 202226226048
Oct 202216516638
Nov 2022504829
Dec 2022565817
Jan 2023444212
Feb 2023545416
Mar 2023353513
Apr 202322228
May 2023181820
Jun 202322226
Jul 2023201810
Aug 2023252515
Sep 202317182
Oct 202321225
Nov 2023383919
Dec 202338389
Jan 2024242414
Feb 202422223
Mar 20241313121
Apr 2024222335
May 2024242215
Jun 2024252714
Jul 2024151315
Aug 202417177
Sep 2024141412
Total21302136852